[artículo]
| Título : |
Does switching to another antipsychotic in patients with clozapine associated granulocytopenia solve the problem? : Case series of 18 patients |
| Tipo de documento: |
texto impreso |
| Autores: |
Behçet Coşar, Autor ; Mustafa Ender Taner, Autor ; Hale Yapc Eser, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 169-173 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Clozapina, Agranulocitosis, Prolongación, Esquizofrenia, Olanzapina, Qetiapina, Antipsicótico |
| Resumen: |
Clozapine is a well-known drug that is used in treatment-resistant schizophrenia, but granulocytopenia, which may lead to a potentially fatal condition such as agranulocytosis, limit its use. The question about which antipsychotic should be used after a diagnosis of clozapine-associated granulocytopenia is difficult to answer, because antipsychotics other than clozapine may also have hematologic toxicity, or they may prolong clozapine-associated granulocytopenia. |
| Link: |
./index.php?lvl=notice_display&id=29385 |
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 169-173
[artículo] Does switching to another antipsychotic in patients with clozapine associated granulocytopenia solve the problem? : Case series of 18 patients [texto impreso] / Behçet Coşar, Autor ; Mustafa Ender Taner, Autor ; Hale Yapc Eser, Autor . - 2022 . - pp. 169-173. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 169-173
| Palabras clave: |
Clozapina, Agranulocitosis, Prolongación, Esquizofrenia, Olanzapina, Qetiapina, Antipsicótico |
| Resumen: |
Clozapine is a well-known drug that is used in treatment-resistant schizophrenia, but granulocytopenia, which may lead to a potentially fatal condition such as agranulocytosis, limit its use. The question about which antipsychotic should be used after a diagnosis of clozapine-associated granulocytopenia is difficult to answer, because antipsychotics other than clozapine may also have hematologic toxicity, or they may prolong clozapine-associated granulocytopenia. |
| Link: |
./index.php?lvl=notice_display&id=29385 |
|
Does switching to another antipsychotic in patients with clozapine associated granulocytopenia solve the problem? en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)
